Metabolism.com
  • Home
  • About us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us
Select Page
Survey Reveals 84% Feel Doctors in US Overly Influenced by Pharmaceutical Industry

Survey Reveals 84% Feel Doctors in US Overly Influenced by Pharmaceutical Industry

by Gary Pepper M.D. | Sep 5, 2016 | diabetes, general health & nutrition, Medical Economics, thyroid cancer

By Gary Pepper, M.D. A survey by metabolism.com reveals that a vast majority of the public believe doctors in the US are overly influenced in their decisions by the pharmaceutical industry.  500 visitors to the website participated in the survey.  419 (84%) answered...

New Diabetes Medications Cost 100 Times More than Established Treatments

by Gary Pepper M.D. | Oct 6, 2014 | diabetes, Family Nutrition Diabetes, general health & nutrition, health insurance, Medical Economics

by Gary Pepper, M.D. “New is not always better.” This caution seems reasonable when considering the value of the recently approved medications for treatment of Type 2 (adult type) diabetes.  These drugs include three new classes of medication referred to...

What’s Inside My Ebook, Metabolism.com?

by Dr. G. Pepper | Jan 1, 2012 | diet, diet and weight loss, fitness, general health & nutrition, health, nutrition, thyroid, weight gain, weight loss

My ebook Metabolism.com is now available; I think you will find it a great resource for many of the common problems members have asked me about over the past 15 years. Buy it now and use it for years to come. Don’t forget to check out the Weight Loss and Weight...

Avandia Law Suit Brings Out the Opportunists

by Dr. G. Pepper | Jul 6, 2011 | diabetes, diet, diet and weight loss, general health & nutrition, health, metabolism, Uncategorized

The lawsuits against Avandia are being prepared and opportunists are lining up for a payday. Unfortunately, everyone else will wind up a loser, and here’s why. Avandia, one of only two available medicines with unique properties to treat diabetes, was approved in...

Are New Diabetes Medications Worth the Money?

by Dr. G. Pepper | May 16, 2011 | diabetes, diet, general health & nutrition, health, metabolism, weight gain

(I don’t think so, and here’s why.) The FDA just announced its approval of linagliptin (Tradjenta), a new diabetes medication developed by Eli Lilly and Company and Boehringer Inglheim. Linagliptin is the third drug to be approved in the class of medications...
« Older Entries

Categories

Polls

  • Polls Archive

After graduating from fellowship in Endocrinology
and Metabolism at Mt. Sinai School of Medicine in
New York, in 1981.

COMPANY

  • Home
  • About Us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us

RESOURCES

  • Blog
  • Terms & Condidtions
  • Privcay Policy
  • Disclaimer

CONTACT US

  • info@metabolism.com
  • P.O. Box 2743, Jupiter,
    Florida 33468

Copyright © 2023 Metabolism.com